Rambam Health Care Campus serves as a referral medical center, unifying fields of medical science and employing a multidisciplinary approach to diagnosis and treatment. Some 75,000 people are hospitalized at RHCC each year, with another 500,000 treated in its outpatient clinics and medical institutes. It also serves as the principal medical facility for the Northern Command of the Israel Defense Forces.
The medical center comprises 36 departments with some 1000 beds, 45 medical units, 9 institutes, 6 laboratories and 30 administrative and maintenance departments. Some of RHCC’s departments are the exclusive providers of comprehensive services for all of northern Israel, including trauma treatment, oncology, and neurosurgery.
As an academic hospital, RHCC also maintains vital teaching and research links with the Technion’s Rappaport Faculty of Medicine, providing a dynamic clinical environment for diagnosis, treatment and research.
Research And DevelopmentRHCC specializes in disease-oriented clinical research, all under the aegis of the Biomedical Discovery Tower. Areas of research include:
- Cardiovascular Disease and Thrombosis & Kidney Disease
- Neurodegenerative Diseases
- Translational Genetics
- Medical Device and Imaging Technology
Vision of Adam Development Plan
Rambam’s 5-10 year, $300 million Vision of Adam development plan for the 21st century aims to meet our medical center’s current and future requirements for functional growth. Plans call for constructing an Underground Emergency Hospital and an above-ground complex of buildings to include a Biomedical Discovery Tower, Cardiovascular Hospital, Children’s Hospital, and Oncology Hospital. The plan also calls for conserving, expanding and fortifying relevant existing structures, with our Emergency Trauma Center a first priority; and for providing open spaces and landscaped green areas. Sixteen thousand square meters of land at the heart of the Rambam campus have been allocated for these purposes.
Biomedical Discovery Tower
The proposed tower represents Rambam’s commitment to nurturing the great potential inherent in the intensely synergetic relationships on campus among clinical-care, research and teaching activities. The project aims to fuse medical knowledge, research and invention, and calls for patient-oriented clinical and translational investigations into cardiovascular disease and thrombosis; neuroscience and neurodegenerative diseases; medical-device and imaging technologies; and cancer — with great hopes invested in the potential of stem-cell studies in relation to regenerative medicine, and population-genetics studies in relation to pharmacogenomics (personalized medicine), for controlling this recalcitrant disease. For this great endeavor, and while exercising rigorous concern for preserving our medical center’s autonomy, Rambam will be inviting investment in the Biomedical Discovery Tower by biomedical-technology companies and entrepreneurs.